SBIR/STTR Research Award

Novel Circular Supercoiling Biosensors for MicroRNA Detection

Award identifier 2e7075e9ee7b4b6e1da43db48997214dc1bee42eb5c714ae609465c45aba6c9dAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$289,322

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SCANOGEN INC.
Proposal award date
2015-07-01
Contract end date
2016-06-30
UEI
JK9PMLM41J77
Solicitation number
PA14-071
Topic code
172

Research abstract

DESCRIPTION provided by applicant MicroRNA miRNA molecules are single stranded and small nt RNA molecules that act as masters regulators of the genome Research on miRNA has increased dramatically since their discovery just over a decade ago and specific miRNA expression patterns are known to influence most cellular activities including stem cell differentiation and tumor growth However the available techniques to detect miRNA are complex and therefore expensive and time consuming limiting the capacity of researchers and clinicians to validate and use miRNA as disease biomarkers In addition their complicated processes normally introduce sequence bias and make them inaccurate and not reproducible Here we propose the development of a quantitative detection assay based on Circular Supercoiling Biosensors Patent Pending for rapid and multiplex detection of miRNA molecules Circular Supercoiling Biosensors CS Biosensors are a novel kind of biosensor based on DNA supercoiling The new biosensors detect miRNA with single nucleotide specificity without any enzymatic reaction and require only a minute incubation step before electrophoresis detection In this proposal we will optimize CS Biosensors and demonstrate the potential of the biosensors by developing a multiplex miRNA detection panel for tumor analysis and comparing its performance with Taqman RT qPCR The first aim focuses on improving the synthesis and application parameters of the biosensors The second aim focuses on the development and characterization of a method to conduct multiplex miRNA detection Our overall goal is to develop a powerful and flexible miRNA detection kit essential for miRNA research and clinical diagnostics The new kit will be better than available tests for medium and low multiplexing applications targets It will have superior quantitative performance and will be faster simpler to use and less expensive PUBLIC HEALTH RELEVANCE We propose the development of biosensors for the rapid and quantitative analysis of microRNA molecules with high sensitivity and specificity We will demonstrate the new technique by detecting multiple microRNAs in clinical samples using a single reaction

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

14 SBIR/STTR records share this UEI (2013–2025). Reported award amounts total $19,036,810. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.